The proposed studies are designed to improve the supply of donor lungs for transplantation by developing technique to prolong the period of safe preservation following extraction. These specific goals of the project are: 1) To utilize newly developed animal models for testing lung viability and function, following preservation; 2) To systematically modify the conditions of preservation to determine the optimum method; 3) To study metabolic and biochemical alterations occurring during lung ischemia and reperfusion in order to increase understanding of the effects of ischemia and reperfusion, and from this, develop new interventions to improve lung preservation. A relatively inexpensive animal screening model has been developed, using ex-vivo perfusion of excised rabbit lungs. This screening model has been improved further by utilizing a donor rabbit as a source of blood for continuous perfusion through the isolated lungs and back into the rabbit, thus extending the period of reperfusion of the isolated lungs following their preservation. This model allows the donor rabbit to pre-treated in various ways with pharmacologic agents in order to attempt to modify the effects of reperfusion on the preserved lungs. The rabbit screening model will be used to study parameters thought to have an influence on lung preservation. Optimum techniques of preservation will be identified and applied in a lung transplant model in dogs in order to more closely simulate the clinical situation. Once methods for safety preserving lungs for 12 hours or more have been developed, techniques will be applied to a survival model of double-lung transplantation in baboons. Nuclear magnetic resonance spectroscopy (NMR) will be utilized to assay in high energy phosphate levels (ATP, ADP), glucose metabolism, and intracellular pH which occur during preservation and reperfusion of lungs. Periodic re-flushing of stored lungs to restore pH, glucose, and high energy phosphates will be evaluated in terms of the effect on metabolism and the effect on function of the preserved lungs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL041281-02
Application #
3358953
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1990-09-01
Project End
1993-08-31
Budget Start
1991-09-16
Budget End
1992-08-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Huang, Howard J; Sugimoto, Seiichiro; Lai, Jiaming et al. (2011) Maintenance of IKK? activity is necessary to protect lung grafts from acute injury. Transplantation 91:624-31
Ray, M; Dharmarajan, S; Freudenberg, J et al. (2007) Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 7:2396-405
Okazaki, M; Kreisel, F; Richardson, S B et al. (2007) Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. Am J Transplant 7:751-8
Ishiyama, Takaaki; Dharmarajan, Sekhar; Hayama, Makio et al. (2005) Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 130:194-201
Dharmarajan, Sekhar; Hayama, Makio; Kozlowski, James et al. (2005) In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation. Am J Transplant 5:1216-25
Krupnick, Alexander Sasha; Gelman, Andrew E; Barchet, Winfried et al. (2005) Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol 175:6265-70
Suda, Takashi; Daddi, Niccolo'; Tagawa, Tsutomu et al. (2005) Recipient intramuscular cotransfection of transforming growth factor beta1 and interleukin 10 ameliorates acute lung graft rejection. J Thorac Cardiovasc Surg 129:926-31
Kuo, Elbert; Bharat, Ankit; Dharmarajan, Sekhar et al. (2005) Animal models for bronchiolitis obliterans syndrome following human lung transplantation. Immunol Res 33:69-81
Tagawa, Tsutomu; Kozower, Benjamin D; Kanaan, Samer A et al. (2004) Gene transfer of tumor necrosis factor inhibitor improves the function of lung allografts. J Thorac Cardiovasc Surg 127:1558-63
Tagawa, Tsutomu; Dharmarajan, Sekhar; Hayama, Makio et al. (2004) Endobronchial gene transfer of soluble type I interleukin-1 receptor ameliorates lung graft ischemia-reperfusion injury. Ann Thorac Surg 78:1932-9; discussion 1939

Showing the most recent 10 out of 59 publications